Sensitivity of leukemic human null lymphocytes to deoxynucleosides

Area of Science:

• Biochemistry
• Cell Biology
• Immunology

Background:

• Leukemic T-lymphocytes exhibit growth inhibition when exposed to deoxynucleosides.
• Epstein-Barr virus-transformed B-lymphocytes show relative resistance to deoxynucleosides.
• Deoxynucleoside sensitivity in T-cells is linked to elevated deoxyribonucleoside triphosphate pools.

Purpose of the Study:

• To investigate the role of ecto-5 extquotesingle-nucleotidase deficiency in deoxynucleoside sensitivity of leukemic lymphocytes.
• To compare the deoxynucleoside sensitivity of null-type leukemic lymphocytes with T-cells.

Main Methods:

• Culturing leukemic T-lymphocytes and null-type lymphocytes.
• Exposing cells to deoxynucleosides (thymidine, deoxyguanosine, deoxyadenosine).
• Measuring ecto-5 extquotesingle-nucleotidase activity and deoxyribonucleoside triphosphate pools.

Main Results:

• Leukemic T-lymphocytes are sensitive to deoxynucleoside-induced growth inhibition.
• Null-type leukemic lymphocytes display similar sensitivity to deoxynucleosides as T-cells.
• Null-type leukemic lymphocytes possess normal ecto-5 extquotesingle-nucleotidase activity.

Conclusions:

• Ecto-5 extquotesingle-nucleotidase deficiency is not the primary factor determining deoxynucleoside sensitivity in leukemic lymphocytes.
• The mechanism of deoxynucleoside sensitivity in leukemic lymphocytes requires further investigation beyond ecto-5 extquotesingle-nucleotidase levels.